User Rating: 5 / 5

Star ActiveStar ActiveStar ActiveStar ActiveStar Active
 

Since it's development by Dr. Douglas Graeb in the early 1980's, the GRAEB score, in various modified versions, has been used as a means of quantifying the volume of blood in the ventricles on an IVH patient. For the CLEAR-III clinical trial, a Modified Graeb Score is used as a measure of clot resolution to inform dosing decisions and to assess the stability of the intraventricular hemorrhage. This course, required for investigators, coordinators and anyone making dosing decisions, describes this important IVH volume approximation and how to properly measure it.

Register to read more ...